SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBridgepoint Regulatory News (BPT)

Share Price Information for Bridgepoint (BPT)

Share Price is delayed by 15 minutes
Get Live Data
244.40    5.60 (2.35%)
Bid:
244.60
Ask:
245.00
Spread: 0.40 (0.164%)
Market Cap: £2.14b
BPT Live PriceLast checked at - London Stock Exchange

Intraday Bridgepoint Share Chart

Additional Listing

25 Mar 2025 16:30

RNS Number : 1186C
Bridgepoint Group plc
25 March 2025
 

Bridgepoint Group plc ("Bridgepoint" or the "Company")

 

Additional Listing

Bridgepoint announces that it intends to issue 1,762,501 ordinary shares of £0.00005 each ("New Ordinary Shares") to satisfy vesting awards under Bridgepoint's Long Term Incentive Plan. The New Ordinary Shares will rank pari passu with existing ordinary shares in issue.

An application has been made for the admission of the New Ordinary Shares to listing on the Official List and to trading on the LSE's main market for listed securities.

Admission is expected to occur on 28 March 2025. 

In conformity with the Financial Conduct Authority's Disclosure and Transparency Rules, Bridgepoint announces that its total issued share capital following the issue of the New Ordinary Shares will comprise:

825,563,402 ordinary shares of £0.00005 each with voting rights; and

500 deferred shares of £81 each, 1 deferred share of £1, and 1 deferred share of £0.01, each with no voting rights.

Bridgepoint holds no shares in treasury. Following the issue of the New Ordinary Shares the total number of voting rights in the Company will therefore be 825,563,402, and this figure may be used by shareholders at such time as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, Bridgepoint under the Disclosure Guidance and Transparency Rules.

 

ENQUIRIES

 

Bridgepoint

 

Analysts and investors

Adam Key

Adam.Key@bridgepointgroup.com+44 7833 748010

 

Media

Christian Jones

Christian.Jones@bridgepointgroup.com

+44 20 7034 3500

 

FGS Global (Public Relations Adviser to Bridgepoint)

James Murgatroyd / +44 20 7251 3801 / +44 7768 254 911

Anjali Unnikrishnan / +44 20 7251 3801 / +44 7826 534 233

Bridgepoint-LON@fgsglobal.com

 

 

Issued by Bridgepoint Group plc

LEI: 213800KFNMVI8PDZX472

Registered in England and Wales no. 11443992

Registered office: 5 Marble Arch, London, W1H 7EJ

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ALSQELFLEXLLBBF
Date   Source Headline
1st Mar 20237:00 amRNSTransaction in Own Shares
28th Feb 20237:00 amRNSTransaction in Own Shares
27th Feb 20237:00 amRNSTransaction in Own Shares
24th Feb 20237:00 amRNSTransaction in Own Shares
23rd Feb 20237:00 amRNSTransaction in Own Shares
22nd Feb 20237:00 amRNSTransaction in Own Shares
21st Feb 20237:00 amRNSTransaction in Own Shares
20th Feb 20237:00 amRNSTransaction in Own Shares
17th Feb 20237:00 amRNSTransaction in Own Shares
16th Feb 20237:00 amRNSTransaction in Own Shares
15th Feb 20237:00 amRNSTransaction in Own Shares
14th Feb 20237:00 amRNSTransaction in Own Shares
13th Feb 20237:00 amRNSTransaction in Own Shares
10th Feb 20237:00 amRNSTransaction in Own Shares
9th Feb 20237:00 amRNSTransaction in Own Shares
8th Feb 20237:00 amRNSTransaction in Own Shares
7th Feb 20237:00 amRNSTransaction in Own Shares
6th Feb 20237:00 amRNSTransaction in Own Shares
3rd Feb 20237:00 amRNSTransaction in Own Shares
2nd Feb 20233:00 pmRNSFormation of ESG Committee
2nd Feb 20237:00 amRNSTransaction in Own Shares
1st Feb 20237:00 amRNSTotal Voting Rights
1st Feb 20237:00 amRNSTransaction in Own Shares
31st Jan 20237:00 amRNSTransaction in Own Shares
30th Jan 20237:00 amRNSTransaction in Own Shares
27th Jan 20237:00 amRNSTransaction in Own Shares
26th Jan 20237:00 amRNSTransaction in Own Shares
25th Jan 20237:00 amRNSTransaction in Own Shares
24th Jan 20237:00 amRNSShare Buyback Programme
22nd Dec 20227:00 amRNSHolding(s) in Company
28th Nov 20226:01 pmRNSStatement regarding Press Speculation
23rd Nov 20227:00 amRNSDirectorate Change
16th Nov 20227:00 amRNSTrading Statement
23rd Sep 202210:10 amRNSDirector/PDMR Shareholding
12th Sep 20223:11 pmRNSChange of Registered Office
5th Aug 20227:00 amRNSDirector/PDMR Shareholding
26th Jul 20227:00 amRNSHalf-year Report
13th May 20227:00 amRNSResult of AGM
6th Apr 20227:00 amRNSHolding(s) in Company
1st Apr 20223:00 pmRNSDirector/PDMR Shareholding
30th Mar 20227:00 amRNSAnnual Report and Accounts and Notice of AGM
24th Mar 20227:00 amRNSPreliminary Results
22nd Mar 20223:00 pmRNSDirector Declaration
16th Dec 20218:56 amRNSDirector Declaration
16th Nov 20217:00 amRNSQuarterly Trading Update
21st Sep 20219:57 amRNSHolding(s) in Company
15th Sep 20217:00 amRNSHalf-Year Update 2021
28th Jul 20214:42 pmRNSHolding(s) in Company
26th Jul 202110:15 amRNSHolding(s) in Company
26th Jul 20218:10 amRNSAdmission to Trading on the London Stock Exchange

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.